FLLHF yields 363.64% · JNJ yields 2.13%● Live data
📍 FLLHF pulled ahead of the other in Year 1
Combined, FLLHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FLLHF + JNJ for your $10,000?
Fullshare Holdings Limited, an investment holding company, engages in the property development, sale of gear products, and property investment activities in the People's Republic of China, the United States, Europe, Australia, and internationally. It operates through five segments: Properties; Tourism; Investment and Financial Services; Healthcare, Education, and Others; and New Energy. The company develops and sells properties, including residential, commercial, hotels, offices, apartments, and shopping malls; and provides construction related services. It also holds and invests in various investments and financial products, such as listed and unlisted securities, bonds, funds, derivatives, structured, and other treasury products; offers investment and financial related consulting services; and operates hotels, as well as sells tourist goods and provides related services. In addition, the company engages in the manufacture, distribution, and sale of mechanical transmission equipment; and manufacture and sale of gear products. Further, it provides healthcare and education products and related services; and green building services comprising technical design and consulting, green management, and construction services. The company was formerly known as Warderly International Holdings Limited and changed its name to Fullshare Holdings Limited in October 2014. The company was founded in 2002 and is headquartered in Admiralty, Hong Kong.
Full FLLHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.